Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-gamma in Chronic Pulmonary Aspergillosis
NCT05653193Phase 2Active, not recruiting
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- May 2024
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in chronic pulmonary aspergillosis (CPA), sponsored by Manchester University NHS Foundation Trust. Started May 2024; status: active, not recruiting.
02
Drugs
interferon gamma-1b
03
Conditions
chronic pulmonary aspergillosis (CPA)
Beyond the preview
Go deeper on NCT05653193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05653193.